As of June 21, 2025, Twinlab Consolidated Holdings Inc (TLCC) reports a ROE (Return on Equity) of 9.86%.
ROE (Return on Equity) measures how well a company generates profits from shareholders' investments, indicating equity efficiency.
Historical Trend of Twinlab Consolidated Holdings Inc's ROE (Return on Equity)
Over recent years, Twinlab Consolidated Holdings Inc's ROE (Return on Equity) has shown significant volatility. The table below summarizes the historical values:
| Date | ROE (Return on Equity) |
|---|---|
| 2023-12-31 | 9.86% |
| 2022-12-31 | 6.56% |
| 2021-12-31 | 12.76% |
| 2020-12-31 | 14.09% |
| 2019-12-31 | 50.71% |
This slight downward trend highlights how Twinlab Consolidated Holdings Inc manages its efficiency in generating profits from shareholders' equity over time.
Comparing Twinlab Consolidated Holdings Inc's ROE (Return on Equity) to Peers
To better understand Twinlab Consolidated Holdings Inc's position, it's useful to compare its ROE (Return on Equity) against industry peers. Below are selected comparisons:
| Company | ROE (Return on Equity) |
|---|---|
| Twinlab Consolidated Holdings Inc (TLCC) | 9.86% |
| Bhang Inc (BHNG.CN) | 1280.73% |
| China Botanic Pharmaceutical Inc (CBPI) | 1100.00% |
| Nextera Enterprises Inc (NXRA) | 680.22% |
| Baikang Biological Group Holdings Ltd (BKSW) | 174.27% |
| Ascendia Brands Inc (ASCBQ) | 134.31% |
Compared to its competitors, Twinlab Consolidated Holdings Inc's ROE (Return on Equity) is about average compared to peers, reflecting standard industry returns on equity investment.